Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Theory development from studies with young women with breast cancer who are BRCA mutation negative.

Hamilton R, Kopin S.

ANS Adv Nurs Sci. 2013 Apr-Jun;36(2):E41-53. doi: 10.1097/ANS.0b013e3182901ff1.

PMID:
23644270
2.

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.

Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW.

Breast J. 2004 Nov-Dec;10(6):475-80.

PMID:
15569201
3.

Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M.

Eur J Hum Genet. 2012 Jan;20(1):4-10. doi: 10.1038/ejhg.2011.146. Epub 2011 Aug 3.

4.

Conditions and consequences of a BRCA mutation in young, single women of childbearing age.

Hamilton R, Hurley KE.

Oncol Nurs Forum. 2010 Sep;37(5):627-34. doi: 10.1188/10.ONF.627-634.

PMID:
20797954
5.

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1579-85.

6.

Being young, female, and BRCA positive.

Hamilton R.

Am J Nurs. 2012 Oct;112(10):26-31, quiz 46, 32.

PMID:
22982855
7.

Living with the BRCA genetic mutation: an uncertain conclusion to an unending process.

DiMillo J, Samson A, Thériault A, Lowry S, Corsini L, Verma S, Tomiak E.

Psychol Health Med. 2013;18(2):125-34. doi: 10.1080/13548506.2012.687827. Epub 2012 Jun 6.

PMID:
22670560
8.

How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.

Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK.

J Clin Oncol. 2007 Aug 20;25(24):3705-11.

9.

Living with the BRCA1 and BRCA2 genetic mutation: learning how to adapt to a virtual chronic illness.

Samson A, DiMillo J, Thériault A, Lowry S, Corsini L, Verma S, Tomiak E.

Psychol Health Med. 2014;19(1):103-14. doi: 10.1080/13548506.2013.779729. Epub 2013 Apr 23.

PMID:
23607692
10.
11.

Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.

Jeffers L, Morrison PJ, McCaughan E, Fitzsimons D.

Eur J Oncol Nurs. 2014 Aug;18(4):411-8. doi: 10.1016/j.ejon.2014.03.007. Epub 2014 Apr 13.

PMID:
24731853
12.

Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.

Nippert I, Schlegelberger B; Consortium 'Hereditary Breast and Ovarian Cancer of The Deutsche Krebshilfe'.

Community Genet. 2003;6(4):249-58.

PMID:
15331871
13.

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.

Quinn GP, Vadaparampil ST, Bower B, Friedman S, Keefe DL.

Minerva Med. 2009 Oct;100(5):371-83. Review.

PMID:
19910890
14.

The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.

Han SA, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.

Fam Cancer. 2013 Mar;12(1):75-81. doi: 10.1007/s10689-012-9578-7.

PMID:
23131904
15.

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.

Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N.

Fam Cancer. 2005;4(2):115-9.

PMID:
15951961
16.

Pretest genetic counseling informs patients with BRCA mutation.

Printz C.

Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922. No abstract available.

17.

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N.

Fam Cancer. 2014 Jun;13(2):143-51. doi: 10.1007/s10689-013-9686-z.

PMID:
24068317
18.

BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.

Shkedi-Rafid S, Gabai-Kapara E, Grinshpun-Cohen J, Levy-Lahad E.

Genet Med. 2012 Jul;14(7):688-94.

PMID:
22481128
19.

Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.

Vanstone M, Chow W, Lester L, Ainsworth P, Nisker J, Brackstone M.

Can Fam Physician. 2012 May;58(5):e258-66.

20.

Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.

Vig HS, McCarthy AM, Liao K, Demeter MB, Fredericks T, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1778-85. doi: 10.1158/1055-9965.EPI-13-0426. Epub 2013 Aug 5.

Items per page

Supplemental Content

Write to the Help Desk